Codexis Secures Multi-Year Technology Upgrade Package for its CodeEvolver Protein Engineering Platform License with Merck
February 04, 2019 16:05 ET
|
Codexis, Inc.
REDWOOD CITY, Calif., Feb. 04, 2019 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading protein engineering company, announces the signing of a new agreement with Merck, through a...
Codexis Reports Third Quarter 2018 Financial Results
November 08, 2018 16:05 ET
|
Codexis, Inc.
Total revenues increase 70% to $16.9 million driven by higher product revenue and R&D revenue across an increased number of customers Conference call begins at 4:30 p.m. Eastern time today ...
Codexis Announces Results of Phase 1a Clinical Trial with CDX-6114
November 08, 2018 07:00 ET
|
Codexis, Inc.
CDX-6114 meets safety and tolerability endpoints REDWOOD CITY, Calif., Nov. 08, 2018 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading protein engineering company, announces top-line...
Codexis to Present at Two Investment Conferences in November
November 07, 2018 16:05 ET
|
Codexis, Inc.
REDWOOD CITY, Calif., Nov. 07, 2018 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading protein engineering company, announces that management will present at two upcoming investment...
Animal Healthcare Market will achieve 4% CAGR to cross $36 billion by 2024: Global Market Insights, Inc.
September 26, 2018 04:00 ET
|
Global Market Insights, Inc
Sellbyville, Delaware, Sept. 26, 2018 (GLOBE NEWSWIRE) -- Global Animal Healthcare Market is expected to surpass USD 36 billion by 2024, as per a new research report by Global Market Insights,...
Non-Alcoholic Wine and Beer Market worth over $25 billion by 2024: Global Market Insights, Inc.
August 01, 2018 07:00 ET
|
Global Market Insights, Inc
Sellbyville, Delaware, Aug. 01, 2018 (GLOBE NEWSWIRE) -- World Non-Alcoholic Wine and Beer Market is expected to beat USD 25 billion by 2024; according to a new research report by Global Market...
Codexis Doses First Subjects in Phase 1a Trial of CDX-6114
July 09, 2018 08:00 ET
|
Codexis, Inc.
REDWOOD CITY, Calif., July 09, 2018 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces that it has dosed the first subjects in a first-in-human Phase...
Codexis to Present at Three Upcoming Investment Conferences
May 29, 2018 07:00 ET
|
Codexis, Inc.
REDWOOD CITY, Calif., May 29, 2018 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces that management will present at three upcoming investment...
Codexis Reports First Quarter 2018 Financial Results
May 10, 2018 16:05 ET
|
Codexis, Inc.
Total revenues increase 76% to $14.0 million on sharply higher R&D revenue Conference call begins at 4:30 p.m. Eastern time today REDWOOD CITY, Calif., May 10, 2018 (GLOBE NEWSWIRE) --...
Codexis to Hold First Quarter 2018 Conference Call on May 10
May 03, 2018 07:00 ET
|
Codexis, Inc.
REDWOOD CITY, Calif., May 03, 2018 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces that it will report first quarter 2018 financial results after...